Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHE.L Regulatory News (GHE)

  • There is currently no data for GHE

Pre-Close Update

27 Jan 2022 07:00

RNS Number : 7702Z
Gresham House PLC
27 January 2022
 

27 January 2022

 

Gresham House plc

 

("Gresham House," "the Group" or "the Company")

 

Pre-Close Update

 

Significant AUM growth of 65% and momentum supports results ahead of expectations

 

Gresham House, (AIM: GHE) the specialist alternative asset manager, is pleased to provide the following unaudited pre-close period update for the financial year ended 31 December 2021.

 

Highlights

Assets Under Management ("AUM") increased by 65% to £6.5 billion (2020: £4.0 billion) Organic growth in AUM of approximately £1.9 billion (c.50%) in the year to 31 December 2021Full year adjusted operating profits expected to be in excess of £19.75 million, excluding performance fees (2020: £12.1 million)Net Performance Fees earned in the year of £1.7 million (2020: £nil)Cash position of £39.1 million and undrawn revolving credit facility of £20.0 million as at 31 December 2021 in addition to existing investments on the balance sheetGroup positioned to continue momentum in 2022, including identified uses of balance sheet capital to support business growth in its specialist asset classes Sustainability focus continues across the Group alongside high levels of employee engagement as recently evidenced by results of 2021 Employee Engagement Survey indicating a 96% advocacy rate

 

 

Trading review

The Group has delivered exceptionally strong profit and AUM growth in 2021. AUM has grown by 65% over the year, driven by strong fundraising, targeted acquisitions and performance. This was particularly noted in the independent valuations of Forestry assets in December 2021 alongside fund performance and inflows into new fund launches and existing funds. Adjusted operating profits are expected to be in excess of £19.75 million for the year to 31 December 2021, the increase since the last trading update on 9 December 2021 reflecting private asset deployment and transaction fees earned ahead of management expectations.

 

Strong fund performance across the Group is pleasing, with many equity funds in top IA quartiles. Consequently, the Group has also received net performance fees of £1.7 million from the equity funds for the year to 31 December 2021 (2020: £nil).

 

The Group has made excellent progress against its five-year goals, as set out in its GH25 strategic plan, and in November it revised its GH25 AUM target upwards by 33% to £8 billion AUM, whilst maintaining the targets of 40% EBITDA margin and 15% ROIC by 2025.

 

The Board was very pleased to note that its recent 2021 Employee Engagement Survey demonstrated high levels of satisfaction and commitment, including a 96% advocacy rate amongst staff, against an external benchmark of 73%.

 

Tony Dalwood, Chief Executive of Gresham House, commented:

"The performance of Gresham House over the course of the year demonstrates the success of the Group's strategy and business model. It is a testament to the capability and energy of those working within Gresham House as we aim to satisfy growing client demand for our sustainable and specialist asset classes and capture the significant opportunity ahead of us."

 

 

- Ends -

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) NO 596/2014.

 

For more information contact:  

 

Gresham House plc  

Tony Dalwood, Chief Executive Officer

Kevin Acton, Chief Financial Officer

 

+44 (0)20 3837 6270

Houston - media and analysts  

Kay Larsen

Joe Burgess

 

gh@houston.co.uk

+44 (0) 20 4 529 0549 

Canaccord Genuity Limited - Nominated Adviser and Joint Broker  

Bobbie Hilliam

Georgina McCooke

 

+44 (0)20 7523 8000

 

Jefferies International Limited - Joint Broker and Financial Adviser 

Paul Nicholls

Max Jones

 

+44 (0)20 7029 8000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETLDIRFIF
Date   Source Headline
24th Apr 20233:27 pmRNSEBT Share Purchase
20th Apr 20237:00 amRNSProgress Update
14th Apr 20237:00 amRNSPosting of Report and Accounts and Notice of AGM
11th Apr 20235:31 pmRNSEBT Share Purchase
3rd Apr 20235:47 pmRNSEBT Share Purchase
31st Mar 20238:19 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSAnnual Results for the year ended 31 December 2022
21st Mar 20232:11 pmRNS2022 Annual Results - revised publication date
15th Mar 20237:00 amRNSNotice of Results
20th Feb 20232:47 pmRNSEBT Share Purchase
13th Feb 20233:06 pmRNSEBT Share Purchase
6th Feb 20235:42 pmRNSEBT Share Purchase
30th Jan 20233:17 pmRNSEBT Share Purchase
25th Jan 20237:00 amRNSPre-Close Update
23rd Jan 20233:03 pmRNSEBT Share Purchase
20th Jan 20237:00 amRNSProgress Update
16th Jan 20234:50 pmRNSEBT Share Purchase
9th Jan 20232:16 pmRNSEBT Share Purchase
9th Jan 20237:00 amRNSLaunch of Irish forestry fund
29th Dec 20229:16 amRNSEBT Share Purchase
23rd Dec 20228:51 amRNSDirector/PDMR Shareholding
22nd Dec 20227:00 amRNSProgress Update
21st Dec 20222:46 pmRNSIncreased Purchase of Shares by EBT
19th Dec 20223:06 pmRNSEBT Share Purchase
12th Dec 20222:11 pmRNSEBT Share Purchase
29th Nov 20229:31 amRNSEBT Share Purchase
22nd Nov 20229:47 amRNSEBT Share Purchase
22nd Nov 20228:56 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSDirector/PDMR Shareholding
10th Nov 20224:03 pmRNSDirector/PDMR Shareholding
9th Nov 20227:00 amRNSTrading Update and Capital Markets Day
7th Nov 20222:41 pmRNSEBT Share Purchase
17th Oct 20225:07 pmRNSEBT Share Purchase
10th Oct 20224:21 pmRNSEBT Share Purchase
3rd Oct 20226:13 pmRNSEBT Share Purchase
21st Sep 20222:48 pmRNSVesting of 2018 Performance Share Plan awards
15th Sep 20227:00 amRNSInterim results
12th Sep 20224:02 pmRNSEBT Share Purchase
12th Sep 20222:47 pmRNSDirector/PDMR Shareholding
5th Sep 20224:01 pmRNSEBT Share Purchase
31st Aug 20227:00 amRNSNotice of Interim Results
30th Aug 20225:34 pmRNSEBT Share Purchase
22nd Aug 20223:47 pmRNSEBT Share Purchase
16th Aug 20227:00 amRNSEBT Share Purchase
1st Aug 20221:44 pmRNSEBT Share Purchase
25th Jul 20223:05 pmRNSEBT Share Purchase
14th Jul 202212:02 pmRNSIntended Purchase of Shares by EBT
13th Jul 20227:00 amRNSTrading Statement
15th Jun 20222:13 pmRNSNotification of Major Holdings
1st Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.